Manufacturer of Controlled Substances; Notice of Registration, 73679-73680 [2011-30690]
Download as PDF
<![CDATA[
73679
Federal Register / Vol. 76, No. 229 / Tuesday, November 29, 2011 / Notices
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. DEA has
investigated United States
Pharmacopeial Convention to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: November 21, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than January 30, 2012.
Dated: November 21, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–30685 Filed 11–28–11; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2011–30687 Filed 11–28–11; 8:45 am]
DEPARTMENT OF JUSTICE
Manufacturer of Controlled
Substances; Notice of Application
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on July 22, 2011,
Noramco Inc., 1440 Olympic Drive,
Athens, Georgia 30601, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
mstockstill on DSK4VPTVN1PROD with NOTICES
Schedule
VerDate Mar<15>2010
15:20 Nov 28, 2011
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Jkt 226001
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated June 23, 2011, and
published in the Federal Register on
July 5, 2011, 76 FR 39126, Chemtos,
LLC, 14101 W. Highway 290, Building
2000B, Austin, Texas 78737, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
Drug Enforcement Administration
Codeine-N-oxide (9053) ...............
Dihydromorphine (9145) ...............
Morphine-N-oxide (9307) .............
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Alfentanil (9737) ...........................
Sufentanil (9740) ..........................
Carfentanil (9743) .........................
Tapentadol (9780) ........................
Fentanyl (9801) ............................
[FR Doc. 2011–30689 Filed 11–28–11; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Drug
Dated: November 21, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on August 9, 2011,
Johnson Matthey, Inc., Pharmaceuticals
Materials, 900 River Road,
Conshohocken, Pennsylvania 19428,
made application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
Schedule
Diphenoxylate (9170) ...................
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone Intermediate (9254) ...
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution and sale to its
customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than January 30, 2012.
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Nabilone (7379) ............................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Etorphine HCL (9059) ..................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levomethorphan (9210) ...............
Levorphanol (9220) ......................
Isomethadone (9226) ...................
Meperidine (9230) ........................
Meperidine-intermediate-A (9232)
Meperidine-intermediate-B (9233)
Meperidine-intermediate-C (9234)
Methadone (9250) ........................
Methadone intermediate (9254) ...
Morphine (9300) ...........................
Thebaine (9333) ...........................
Dihydroetorphine (9334) ...............
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
Racemethorphan (9732) ..............
Racemorphan (9733) ...................
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances in bulk for distribution to its
customers for use as reference
standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Chemtos, LLC, to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
E:\FR\FM\29NON1.SGM
29NON1
73680
Federal Register / Vol. 76, No. 229 / Tuesday, November 29, 2011 / Notices
Dated: November 21, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2011–30690 Filed 11–28–11; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Chattem Chemicals Inc. to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Chattem Chemicals Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
concerning the proposed extension of
the O*NET (Occupational Information
Network) Data Collection Program. A
copy of the proposed information
collection request (ICR) can be obtained
by contacting the office listed below in
the addressee section of this notice or by
accessing: https://www.onetcenter.org/
ombclearance.html
DATES: Written comments must be
submitted to the office listed in the
ADDRESSES section below on or before
January 30, 2012.
ADDRESSES: Send comments to the
Employment and Training
Administration, 200 Constitution
Avenue NW., Room C4526, Washington,
DC 20210, Attention: Pam Frugoli. Fax:
(202) 693–3015 (this is not a toll-free
number). Email: o-net@doleta.gov.
FOR FURTHER INFORMATION CONTACT:
Lauren Wright, Telephone number (202)
693–3045 (this is not a toll-free
number), Email: wright.lauren@dol.gov.
SUPPLEMENTARY INFORMATION:
Dated: November 21, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
this time. DEA has investigated
Chemtos, LLC, to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
I. Background
The O*NET Data Collection Program
is an ongoing effort to collect and
maintain current information on the
detailed characteristics of occupations
and skills for more than 900
occupations. The resulting database
provides the most comprehensive
standardized source of occupational and
skills information in the nation. O*NET
information is used by a wide range of
audiences, including individuals
making career decisions, public
agencies and schools providing career
exploration services or education and
training programs, and businesses
making staffing and training decisions.
The O*NET system provides a common
language, framework and database to
meet the administrative needs of various
federal programs, including workforce
investment and training programs
supported by funding from the
Departments of Labor, Education, and
Health and Human Services.
Section 309 of the Workforce
Investment Act requires the Secretary of
Labor to oversee the ‘‘development,
maintenance, and continuous
improvement of a nationwide
employment statistics system’’ which
shall include, among other components,
‘‘skill trends by occupation and
industry.’’ The O*NET database
provides:
• Detailed information for more than
900 occupations.
• Descriptive information using
standardized descriptors for skills,
abilities, interests, knowledge, work
values, education, training, work
context, and work activities.
[FR Doc. 2011–30695 Filed 11–28–11; 8:45 am]
By Notice dated June 7, 2011, and
published in the Federal Register on
June 16, 2011, 76 FR 35242, Chattem
Chemicals Inc., 3801 St. Elmo Avenue,
Building 18, Chattanooga, Tennessee
37409, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
mstockstill on DSK4VPTVN1PROD with NOTICES
Drug
Schedule
4–Methoxyamphetamine (7411) ...
Dihydromorphine (9145) ...............
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Pentobarbital (2270) .....................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
VerDate Mar<15>2010
15:20 Nov 28, 2011
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Jkt 226001
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Proposed Information Collection
Request Submitted for Sixty Days’
Public Comment; O*NET Data
Collection Program, Extension of
Currently Approved Collection Without
Change
Employment and Training
Administration, Labor.
ACTION: Notice.
AGENCY:
The Department of Labor, as
part of its continuing effort to reduce
paperwork and respondent burden,
conducts a preclearance consultation
program to provide the general public
and federal agencies with an
opportunity to comment on proposed
and/or continuing collections of
information in accordance with the
Paperwork Reduction Act of 1995
(PRA95) [44 U.S.C. 3506(c)(2)(A)]. This
program helps to ensure that requested
data can be provided in the desired
format, reporting burden (time and
financial resources) is minimized,
collection instruments are clearly
understood, and the impact of collection
requirements on respondents can be
properly assessed. Currently, the
Employment and Training
Administration is soliciting comments
SUMMARY:
PO 00000
Frm 00099
Fmt 4703
Sfmt 4703
E:\FR\FM\29NON1.SGM
29NON1
]]>Agencies
[Federal Register Volume 76, Number 229 (Tuesday, November 29, 2011)]
[Notices]
[Pages 73679-73680]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-30690]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 23, 2011, and published in the Federal
Register on July 5, 2011, 76 FR 39126, Chemtos, LLC, 14101 W. Highway
290, Building 2000B, Austin, Texas 78737, made application by renewal
to the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Lisdexamfetamine (1205).................... II
Methylphenidate (1724)..................... II
Nabilone (7379)............................ II
Phenylacetone (8501)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Etorphine HCL (9059)....................... II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Ecgonine (9180)............................ II
Ethylmorphine (9190)....................... II
Hydrocodone (9193)......................... II
Levomethorphan (9210)...................... II
Levorphanol (9220)......................... II
Isomethadone (9226)........................ II
Meperidine (9230).......................... II
Meperidine-intermediate-A (9232)........... II
Meperidine-intermediate-B (9233)........... II
Meperidine-intermediate-C (9234)........... II
Methadone (9250)........................... II
Methadone intermediate (9254).............. II
Morphine (9300)............................ II
Thebaine (9333)............................ II
Dihydroetorphine (9334).................... II
Levo-alphacetylmethadol (9648)............. II
Oxymorphone (9652)......................... II
Racemethorphan (9732)...................... II
Racemorphan (9733)......................... II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances in bulk for distribution to its customers for use
as reference standards.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Chemtos, LLC, to manufacture the listed basic classes of controlled
substances is consistent with the public interest at
[[Page 73680]]
this time. DEA has investigated Chemtos, LLC, to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance
with 21 CFR 1301.33, the above named company is granted registration as
a bulk manufacturer of the basic classes of controlled substances
listed.
Dated: November 21, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-30690 Filed 11-28-11; 8:45 am]
BILLING CODE 4410-09-P
